Study on Sequential Immunization of Omicron Inactivated COVID-19 Vaccine and Prototype Inactivated COVID-19 Vaccine in Population Aged 18 Years Old and Above
Clinical trial NCT05374954 · UNKNOWN
Trial details
- NCT number
- NCT05374954
- Sponsor
- China National Biotec Group Company Limited
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-10
- Primary completion
- 2022-09-25
- Enrollment
- 4200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.